Thomas Papathomas
National and Kapodistrian University of Athens
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas Papathomas.
International Journal of Infectious Diseases | 2008
Athina Androulaki; Thomas Papathomas; George Liapis; Ioannis Papaconstantinou; Maria Gazouli; Nikos Goutas; Konstantinos Bramis; Alexandros Papalambros; Andreas C. Lazaris; Efstathios Papalambros
BACKGROUND Inflammatory pseudotumor is a relatively rare entity; originally identified in the lung, it has been described in multiple extrapulmonary anatomic locations. CASE REPORT We report on the unusual case of an inflammatory pseudotumor associated with Mycobacterium tuberculosis infection, which was initially mistaken for a renal malignancy both in clinical and radiological settings. We additionally present three brief reviews concerning: (1) infectious agents postulated to induce morphological changes of an inflammatory pseudotumor; (2) mycobacterial pseudotumors; and (3) distinction from inflammatory myofibroblastic tumors of the renal pelvis. CONCLUSIONS The present case highlights the diagnostic importance of PCR-based detection of mycobacterial DNA in granulomatous tissue responses. It is of crucial importance that clinicians are aware of this unusual manifestation of mycobacterial infection to ensure that pertinent laboratory evaluation is employed and appropriate treatment is administered in order to avoid potential clinical implications.
Inhalation Toxicology | 2008
G. E. Philippakis; Andreas C. Lazaris; Thomas Papathomas; C. Zissis; G. Agrogiannis; Georgia-Heleni Thomopoulou; Aphrodite Nonni; Konstantinos Xiromeritis; P. Nikolopoulou-Stamati; John Bramis; E. Patsouris; Despina Perrea; I. Bellenis
Endotoxin is a major cause of endotoxinemia, sepsis, and pneumonia due to gram-negative bacteria. Experimental endotoxin administration via the tracheal route has been extensively used to study the biological and pathophysiologic pathways of inflammation. In particular, experimental endotoxin instillation in the respiratory tree has allowed an extended research with regard to the local response of the lungs to the pathogenic stimulus. This study aims (a) to define early events in the inflammatory cascade and (b) to evaluate the efficacy of adrenaline to ameliorate the acute pulmonary inflammation in vivo after administration of intratracheal lipopolysaccharide (LPS) in an in vivo animal model. Two groups of animals were used for that purpose, a control group (single LPS administration) and a study group (subcutaneous adrenaline infusion following LPS administration). We found that mononuclear recruitment, along with an increased population of CD4+ T lymphocytes, is an early event during the course of LPS-challenged inflammation. In the study group, we determined that adrenaline mediated the lung inflammation in a statistically significant degree. By the use of immunohistochemistry, we identified (1) an increased population of CD4+ T lymphocytes in the inflammatory infiltrate, further endorsing the hypothesis that T-helper lymphocytes, along with macrophages, secrete cytokines which amplify the inflammatory response, and (2) an upregulation of ICAM-1 expression, suggesting an important role in the early pathogenesis of LPS-induced acute lung injury. Our study establishes that systemic adrenaline administration after LPS instillation may ameliorate the inflammatory lung response in vivo.
International Journal of Gynecological Cancer | 2007
Athina Androulaki; Thomas Papathomas; Paraskevi Alexandrou; Andreas C. Lazaris
Low-grade endometrial stromal sarcoma (ESS) is an uncommon neoplasm, which has a highly recurrent nature. A review of the literature revealed that only one case of low-grade ESS, arising within the vulva from a focus of endometriosis, has been previously published. We describe an additional case of low-grade ESS arising within the vulva and to the best of our knowledge the first report of low-grade ESS metastasized to clitoris. A 46-year-old woman was admitted to our hospital due to a heavy uterine bleeding. A physical examination revealed a lesion in clitoris, which exhibited a densely cellular mesenchymal neoplasm on microscopy. On the basis of the pathologic features alone, a differential diagnosis of a low-grade ESS and cellular leiomyoma was considered. Seven months later, the patient presented again with excessive uterine bleeding and a total hysterectomy was performed. A tumor of white-tan, whorled appearance was found. Its features were suggestive of low-grade ESS. Taking into account the possible extrauterine location of an ESS and reviewing the first case, a diagnosis of rare low-grade ESS metastasized to clitoris was made
Pathology & Oncology Research | 2009
Maria Ioannou; Efstathios Stathakis; Andreas C. Lazaris; Thomas Papathomas; Evangelos Tsiambas; George K. Koukoulis
We histologically and immunohistochemically studied 95 bone marrow (BM) reactive plasmacytoses. Ten biopsies from plasma cell myeloma (PCM) patients served as a control group. In addition, we studied 10 monoclonal gammopathy of undetermined significance (MGUS) cases. Histologically, plasmacytosis varied between 5% and 25% with an interstitial pattern of plasma cell (PC) distribution being characteristically displayed. Immunohistochemically, we did not find any CD56/NCAM nor cyclin D1 expression in all biopsies (95 of 95, 100%), not even a weak, doubtful one; PCs were all polyclonal and CD138 positive. On the contrary, myeloma-associated PCs showed monoclonality for κ- or λ- light chain and strong CD56/NCAM immunoreactivity (8 of 10, 80%); four of them were cyclin D1 positive. Osteoblasts exhibited similar CD56/NCAM expression in both groups. Our data confirm the diagnostic utility of CD56/NCAM in the phenotypic characterization of polyclonal plasma cells, suggesting an important role of this particular immunomarker in the BM trephine study of polyclonal versus neoplastic plasmacytic infiltrations.
Cytopathology | 2008
Ekaterini Politi; Andreas C. Lazaris; M. Kehriotis; Thomas Papathomas; Nikolakopoulou E; Helen Koutselini
Objective: The aim of the present study was to evaluate the expression of pan‐cadherin and β‐catenin in cervical smears with various types of infectious agents.
Endocrine Pathology | 2006
Athina Androulaki; Vassiliki Syriou; Andreas C. Lazaris; Thomas Paterakis; Dimitrios Pikazis; Thomas Papathomas; Margarita Anapliotou
We report the case of a 70-yr-old woman with maltoma of the thyroid, Sjögren’s syndrome, and a history of Hashimoto’s thyroiditis. The patient underwent a total thyroidectomy for a recently growing mass of the thyroid, while being treated with l-thyroxine for Hashimoto’s thyroiditis. Postoperatively, routine histologic examination was consistent with the diagnosis of chronic lymphocytic thyroiditis of autoimmune etiology. Three years later, the patient presented with high temperature, anorexia, and coughing. This time, a microscopic examination of deeper thyroid tissue sections and an immunohistochemical study revealed a low-grade, non-Hodgkin lymphoma, MALT type. Simultaneously, the diagnosis of Sjögren’s syndrome was established and the patient is currently under investigation for generalized lymphoma. This case clearly demonstrates the difficulty in differentially diagnosing Hashimoto’s thyroiditis from low-grade MALT lymphoma by the use of routine histologic examination.
Expert Opinion on Investigational Drugs | 2008
A. Lekas; Thomas Papathomas; Athanasios Papatsoris; Charalambos Deliveliotis; Andreas C. Lazaris
Background: Albeit transitional cell carcinoma of the urinary bladder is a chemosensitive neoplasm, metastatic disease is related with poor prognosis and short-term survival data. Objective: Cisplatin-based combination chemotherapy is recognised as the golden standard therapy for patients with inoperable locally advanced or metastatic bladder cancer. However, owing to treatment-related toxicities and short-response durations, novel treatment options or agents, with both enhanced efficacy and tolerability, have been sought. Methods: Reviewing the current status and addressing the future of novel anticancer therapeutics in metastatic urinary bladder cancer. Results/conclusion: Non-platinum, single agents, such as gemcitabine and taxanes, as well as multidrug regimens in doublet or triplet chemotherapeutic combinations are regarded as promising alternatives. Dose intensification of conventional regimens, dose-dense sequential administration of new agents, the use of molecular markers for predicting chemosensitivity and the integration of biologically targeted agents to enhance chemotherapeutic efficacy are promising approaches.
Anticancer Research | 2006
A. Lekas; Andreas C. Lazaris; C. Deliveliotis; M. Chrisofos; Christina Zoubouli; Dimitrios Lapas; Thomas Papathomas; Ioannis Fokitis; Lydia Nakopoulou
Cancer Chemotherapy and Pharmacology | 2009
Nicolas Tsavaris; Andreas C. Lazaris; Christos Kosmas; Panagiotis Gouveris; Nikolaos Kavantzas; Petros Kopterides; Thomas Papathomas; George Arapogiannis; Haralambos Zorzos; Vassiliki Kyriakou; Efstathios Patsouris
European Journal of Endocrinology | 2006
Andreas C. Lazaris; Sofia Tseleni-Balafouta; Thomas Papathomas; Theodore Brousalis; Georgia Thomopoulou; George Agrogiannis; Efstratios Patsouris